OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. It operates through the US and UK ...

The measurements were conducted as part of a research project to "restore the original colors of the gold-leaf backing of fusuma-e drawn by Maruyama Okyo (1733-1795), a painter of the mid to late Edo ...

Get the latest news on OKYO Pharma stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on OKYO Pharma performance ...

In a remarkable display of market confidence, OKYO Pharma stock has surged to a 52-week high of $1.74, with the current price at $1.71. According to InvestingPro data, the company’s stock shows strong ...

The measurements were conducted as part of a research project to "restore the original colors of the gold-leaf backing of fusuma-e drawn by Maruyama Okyo (1733?1795), a painter of the mid to late ...

The purpose of the measurements was to investigate scientifically the artistic intention of Maruyama Okyo, the historical context in which he painted, and the impact that restoration would have.